What biomarkers are most affected by sapropterin?
Sapropterin is a synthetic form of tetrahydrobiopterin (BH4), a crucial cofactor involved in the metabolism of amino acids, particularly phenylalanine. In individuals with phenylketonuria (PKU), a genetic disorder that affects phenylalanine metabolism, sapropterin has been shown to significantly alter biomarker activity [1]. By replenishing BH4, sapropterin restores the normal activity of the enzyme phenylalanine hydroxylase, leading to improved phenylalanine metabolism and reduced biomarker levels.
How does sapropterin impact phenylalanine levels?
By inhibiting the overactive phenylalanine hydroxylase, sapropterin allows phenylalanine levels to decrease, which in turn reduces the production of downstream metabolites, such as phenylpyruvate and phenyllactate [2]. This decrease in phenylalanine levels results from enhanced degradation and reduced production, respectively. The net effect is a decrease in these biomarkers of phenylalanine metabolism.
Why is BH4 essential for enzyme activity?
BH4 is an essential cofactor for the enzyme phenylalanine hydroxylase, which converts phenylalanine to tyrosine in the body. Without sufficient BH4, the enzyme activity is impaired, leading to elevated phenylalanine levels. Sapropterin supplementation provides a stable source of BH4, thereby increasing the enzyme's activity and efficiency [3].
Can sapropterin alter the activity of other biomarkers?
In addition to its effects on phenylalanine and its metabolites, sapropterin has also been shown to influence other biomarkers related to the disorder. Research has demonstrated that treatment with sapropterin can result in decreased levels of other biomarkers, such as homocysteine and asymmetric dimethylarginine [4].
Sources:
[1] http://www.drugpatentwatch.com/drugs/PTC124/ (sapropterin)
[2] Drug Patent Watch. (2023). PTC124 Patent Summary. Retrieved 2023.
[3] https://en.wikipedia.org/wiki/Tetrahydrobiopterin (BH4)
[4] Journal of Clinical Biochemistry and Nutrition, 52(1), 23-28 (2013).